Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study (P3.016)

Zoltan Mari; Khashayar Dashtipour; Joseph Jankovic; Charles H. Adler; Marc Schwartz; Mitchell F. Brin

Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study (P3.016)

Zoltan Mari, Khashayar Dashtipour, Joseph Jankovic, Charles H. Adler, Marc Schwartz, Mitchell F. Brin

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neurology
Volume	88
State	Published - Apr 18 2017

Disciplines

Physical Therapy
Medicine and Health Sciences

OpenUrl availability

Full text

Cite this

@article{49b29c238e2049a9900698472ee14969,

title = "Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study (P3.016)",

author = "Zoltan Mari and Khashayar Dashtipour and Joseph Jankovic and Adler, {Charles H.} and Marc Schwartz and Brin, {Mitchell F.}",

note = "Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE) study.",

year = "2017",

month = apr,

day = "18",

language = "American English",

volume = "88",

journal = "Neurology",

}

TY - JOUR

T1 - Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study (P3.016)

AU - Mari, Zoltan

AU - Dashtipour, Khashayar

AU - Jankovic, Joseph

AU - Adler, Charles H.

AU - Schwartz, Marc

AU - Brin, Mitchell F.

N1 - Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE) study.

PY - 2017/4/18

Y1 - 2017/4/18

UR - https://n.neurology.org/content/88/16_Supplement/P3.016

M3 - Article

VL - 88

JO - Neurology

JF - Neurology

ER -

Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study (P3.016)

Disciplines

OpenUrl availability

Other files and links

Cite this